Abstract:Background: Endometritis is an inflammatory disease of the endometrium that is closely associated with endometrial dysfunction, a higher incidence of recurrent pregnancy loss, and an increased probability of infertility. The disordered communication induced by infections, stress, or surgical injuries may destruct the healthy endometrial milieu, leading to endometritis. SCM-198, an alkaloid active component of Leonurus japonicus Houtt, possesses various biological activities, especially anti-inflammatory effects. However, the molecular mechanism of SCM-198 in preventing endometritis has not been completely elucidated. Methods: In vitro, we evaluated the inflammatory level of LPS-stimulated human endometrial stromal cells (hESCs), macrophages or their coculture after SCM-198 treatment, via RT-PCR, ELISA, Western blot and Flow cytometry. In vivo, endometritis C57BL/6J mice stimulated by LPS were vaginally or intraperitoneally injected with SCM-198 and the uterus tissues were studied compared to untreated mice. Findings: We found that SCM-198 could prevent lipopolysaccharide (LPS)-induced endometrial inflammation in hESCs and a mouse model. SCM-198 directly attenuated LPS-induced inflammation via TLR-4/NF-κB signaling in hESCs. SCM-198 also efficiently decreased CCL2 production by endometrial stromal cells (ESCs), which inhibited the endometrial infiltration of monocytes and promoted local macrophage switching to M2 via a CCL2/CCR2 interaction. Polarized M2 macrophages protected ESCs against inflammatory damage, thereby reinforcing the therapeutic effect of SCM-198. Interpretation: Our study is the first to propose the concept that dysregulated communication between ESCs and macrophages via CCL2/CCR2 axis boosting local macrophage enrichment and proinflammation amplification is a critical mechanism of the occurrence of endometritis. SCM-198 can inhibit CCL2 production in ESCs and interrupt the CCL2-mediated ESC-macrophage interaction loop. It also provided a new entry point for the prevention and treatment of endometritis in clinical practice. Funding Statement: This work was supported by grant from the Nature Science Foundation from National Nature Science Foundation of China (NSFC) (31970859, 81630036, 91542116 and 31570920 to MRD), the National Key R&D Program of China (2017YFC1001403 to MRD and DJL), the Program of Shanghai Academic/Technology Research Leader (17XD1400900 to MRD), the Innovation‑oriented Science and Technology Grant from NPFPC Key Laboratory of Reproduction Regulation (CX2017‑2 to MRD).Declaration of Interests: The authors declare that they have no conflicts of interest.Ethics Approval Statement: The collection and use of these samples were approved by the Human Research Ethics Committee of the Obstetrics and Gynecology Hospital of Fudan University (No. Kyy2016-4) (Shanghai, China). All participants provided written informed consent. All methods were conducted in accordance with the approved guidelines. All experimental procedures that involved animals were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (China), and permission for their use was provided by the Human Research Ethics Committee of Obstetrics and Gynecology Hospital of Fudan University.

SCM-198 Alleviates Endometriosis by Suppressing Estrogen-ERα Mediated Differentiation and Function of CD4+CD25+ Regulatory T Cells

SCM-198 Prevents Endometriosis by Reversing Low Autophagy of Endometrial Stromal Cell via Balancing ERα and PR Signals

SCM-198 Prevents Endometriosis by Reversing Low Autophagy of Endometrial Stromal Cell <i>via</i> Balancing ERa and PR Signals

SCM-198 Prevents Endometriosis By Reversing Low Autophagy Levels Of Endometriotic Stromal Cells Via Inhibiting TNF-Α-Aromatase-Estrogen-Erα Pathway And Promoting PR Expression

Sodium Cromoglycate Attenuates Experimental Endometriosis in Rats by Regulating Mast Cells

Abstract #1504468: Estrogen Attenuates Ferroptosis Via Estrogen Receptor (ER) Β/erα/lipocalin 2 Pathway in Endometriosis

Pgpm_a_354957 377..392

Transcriptome-Based Analysis Reveals Therapeutic Effects of Resveratrol on Endometriosis in Arat Model.

SCM-198 ameliorates endometrial inflammation via suppressing the LPS-JNK-cJUN/cFOS-TLR4-NF-κB pathway

Cell Membrane Camouflaged and ROS Responsive Nanosomes for Targeted Endometriosis Therapy Via Reversing Inflammatory, Low-Autophagy, and Immunotolerant Microenvironment

SCM-198 Prevents Endometritis by Interrupting the CCL2-Mediated Endometrial Stromal Cell-Macrophage Interaction Loop

SCM-198 Protects Endometrial Stromal Cells from Oxidative Damage Through Bax/Bcl-2 and ERK Signaling Pathways.

Repression of FBXW7 by HES5 contributes to inactivation of the TGF-β signaling pathway and alleviation of endometriosis.

Wenshen Xiaozheng Tang alleviates fibrosis in endometriosis by regulating differentiation and paracrine signaling of endometrium-derived mesenchymal stem cells

Suppression of Autophagy and HCK Signaling Promotes PTGS2high FCGR3− NK Cell Differentiation Triggered by Ectopic Endometrial Stromal Cells

Resveratrol protected against the development of endometriosis by promoting ferroptosis through miR-21-3p/p53/SLC7A11 signaling pathway

Exosomal Mir-22-3p Derived from Peritoneal Macrophages Enhances Proliferation, Migration, and Invasion of Ectopic Endometrial Stromal Cells Through Regulation of the SIRT1/NF-κB Signaling Pathway

Estrogen Restricts the Apoptosis of Endometrial Stromal Cells by Promoting TSLP Secretion.

Caulis Sargentodoxae Prescription Plays a Therapeutic Role with Decreased Inflammatory Cytokines in Peritoneal Fluid in the Rat Endometriosis Model

Juan-tong-yin potentially impacts endometriosis pathophysiology by enhancing autophagy of endometrial stromal cells via unfolded protein reaction-triggered endoplasmic reticulum stress

Evodiamine suppresses endometriosis development induced by early EBV exposure through inhibition of ERβ